...
首页> 外文期刊>AIPLA quarterly journal >VACCINES...PATENT ELIGIBLE NOW OR NO? AN ASSESSMENT OF THE PATENT ELIGIBILITY OF AN EBOLA VACCINE IN LIGHT OF RECENT SUPREME COURT DECISIONS
【24h】

VACCINES...PATENT ELIGIBLE NOW OR NO? AN ASSESSMENT OF THE PATENT ELIGIBILITY OF AN EBOLA VACCINE IN LIGHT OF RECENT SUPREME COURT DECISIONS

机译:疫苗...现在是否有合格的专利?根据最近的最高法院判决对埃博拉疫苗的专利资格进行评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Vaccines are vital to today's society and its approach to human health, especially in light of the recent Ebola outbreak. Thousands of people died last year as a result of the Ebola virus. The constant intellectual property debate may delay research and development in the vaccine industry, resulting in the delay of vaccine distribution to those who need them. The production and distribution of an Ebola vaccine would drastically lessen the spread of the disease and save countless lives.
机译:疫苗对当今社会及其对人类健康的影响至关重要,尤其是考虑到最近爆发的埃博拉疫情。去年,由于埃博拉病毒死亡数千人。知识产权争议不断,可能会延缓疫苗行业的研究与开发,从而导致疫苗分发给有需要的人的时间推迟。埃博拉疫苗的生产和分发将大大减少该疾病的传播并挽救无数生命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号